Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

Brent Richards

CEO

5 Prime Sciences

Montreal, Canada

1 profile visit

I'm the CEO of 5 Prime Sciences where we use human genetics and other omics to accelerate our partners' drug development programs.

My organisation

Drug development fails at a ~90% rate because fundamental biology fails to translate to humans. 5Prime Sciences is a global leading expert that acts as the computational radar for the pharmaceutical industry, replacing guesswork with definitive genetic evidence to solve this root cause. We develop advanced multi-omics tools—powered by our proprietary Centromere™ platform and PRIMEVault™ — to act as an extension of your R&D team. We bring essential information to our partners by answering four critical questions before major capital is deployed: Does the target truly drive disease? Will modulating it change outcomes? Are there safety risks? Are we selecting the right patients? By validating human biology, we multiply your probability of clinical success up to 4x . Trusted by top-tier pharma with an 80% partner return rate, our evidence-driven approach delivers concrete results: enabling 190M biotech fundraises, halting>100M late-stage trial failures, and de-risking >$600M pharma acquisitions. The best medicines start with the best targets. We provide the evidence to stop weak programs early and the confidence to accelerate the right ones.
Read more

About me

My motivation stems from a desire to help my patients. As an endocrinologist and professor of medicine at McGill University, we founded 5 Prime Sciences to help our partners in industry identify and validate drug targets and biomarkers that cause disease in humans. This has already led to several drug development programs.

Social media